HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction.

AbstractOBJECTIVES:
We investigated clinical implications of serum tenascin-C (TN-C) levels in patients with acute myocardial infarction (AMI).
BACKGROUND:
Tenascin-C, an extracellular matrix glycoprotein, is not normally expressed in the adult heart, but transiently appears during pathological conditions and plays important roles in tissue remodeling.
METHODS:
Serum TN-C levels were measured by ELISA in 105 AMI patients at various time points, in 10 old myocardial infarction (OMI) patients, and 20 normal controls.
RESULTS:
The mean serum TN-C level of AMI patients on admission (63.3 +/- 30.1 ng/ml) was significantly higher than that of controls and OMI (30.9 +/- 8.8 ng/ml and 27.4 +/- 11.7 ng/ml, respectively, p < 0.01), and peaked at 5 days (83.2 +/- 43.0 ng/ml). Follow-up examination (mean: 43.9 +/- 19.6 months) revealed that 25 of 105 AMI (23.8%) patients showed left ventricular (LV) remodeling (> or =20% end-diastolic volume increase), and in 15 (14.3%), major adverse cardiac events (MACE) were detected. The peak TN-C level was significantly higher in the remodeling group than the nonremodeling group (112 +/- 37 ng/ml vs. 66 +/- 29 ng/ml; p < 0.0001). By receiver-operating characteristic (ROC) analysis, TN-C levels clearly discriminated prediction of LV remodeling and MACE compared with other variables including plasma B-type natriuretic peptide, creatine kinase-MB, and LV function. Best predictive values of TN-C for remodeling and MACE were 84.8 and 92.8 ng/ml, respectively. Cox proportional hazards model analysis showed that TN-C was an important independent predictor of MACE.
CONCLUSIONS:
The findings suggest that serum TN-C levels might be useful in predicting LV remodeling and prognosis after AMI.
AuthorsAkira Sato, Kazutaka Aonuma, Kyoko Imanaka-Yoshida, Toshimichi Yoshida, Mitsuaki Isobe, Daisuke Kawase, Noriaki Kinoshita, Yoshio Yazaki, Michiaki Hiroe
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 47 Issue 11 Pg. 2319-25 (Jun 06 2006) ISSN: 1558-3597 [Electronic] United States
PMID16750702 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tenascin
Topics
  • Aged
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Heart Diseases (etiology, physiopathology)
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, complications, physiopathology)
  • Myocardium (metabolism)
  • Osmolar Concentration
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Severity of Illness Index
  • Survival Analysis
  • Tenascin (blood, metabolism)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: